Kathmere Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
4,503
+261
+6% +$54.2K 0.06% 230
2026
Q1
$896K Buy
4,242
+49
+1% +$10.6K 0.06% 232
2025
Q4
$862K Buy
4,193
+102
+2% +$19.2K 0.06% 216
2025
Q3
$642K Buy
4,091
+65
+2% +$10K 0.05% 245
2025
Q2
$676K Sell
4,026
-28
-0.7% -$4.16K 0.05% 225
2025
Q1
$559K Sell
4,054
-14
-0.3% -$1.78K 0.05% 231
2024
Q4
$481K Buy
4,068
+182
+5% +$21.2K 0.04% 237
2024
Q3
$429K Sell
3,886
-81
-2% -$8.47K 0.04% 225
2024
Q2
$390K Sell
3,967
-302
-7% -$30.8K 0.04% 212
2024
Q1
$478K Sell
4,269
-77
-2% -$8.31K 0.05% 173
2023
Q4
$438K Buy
4,346
+101
+2% +$10K 0.06% 155
2023
Q3
$369K Buy
4,245
+574
+16% +$51.9K 0.05% 159
2023
Q2
$347K Buy
3,671
+978
+36% +$82.6K 0.05% 150
2023
Q1
$203K Buy
+2,693
New +$203K 0.03% 207
2021
Q1
Sell
-31
Closed -$2K 167
2020
Q4
$2K Hold
31
﹤0.01% 378
2020
Q3
$1K Buy
+31
New +$1.59K ﹤0.01% 362

Other funds holding CAH

Kathmere Capital Management's CAH Position: Q2 2026 in Review

Kathmere Capital Management increased its Cardinal Health (CAH) stake by 6.2% in Q2 2026, buying an estimated $54.2K and bringing the position to 4,503 shares worth $1.07M. The position accounts for 0.06% of the portfolio, ranked #230.

Kathmere Capital Management first reported a position in CAH in Q3 2020 and has held it in 16 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Kathmere Capital Management held 4,503 shares of Cardinal Health worth $1.07M as of Q2 2026.
  • Kathmere Capital Management bought 261 Cardinal Health shares in Q2 2026, an estimated $54.2K.
  • Cardinal Health made up 0.06% of Kathmere Capital Management's portfolio in Q2 2026, its #230 holding.
  • Kathmere Capital Management first reported a position in Cardinal Health in Q3 2020 and has held it in 16 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.